Katelyn Souza, MSOT, OTR/L in Acushnet, MA - Occupational Therapist

Katelyn Souza, MSOT, OTR/L is a Occupational Therapist based in Acushnet, Massachusetts. Katelyn Souza is licensed to practice in Massachusetts (license number 13967) and her current practice location is 96 Peckham Rd, Acushnet, Massachusetts. She can be reached at her office (for appointments etc.) via phone at (774) 328-2052.

NPI number for Katelyn Souza is 1144804923 and her current mailing address is 96 Peckham Rd, Acushnet, Massachusetts. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1144804923.

Contact Information

	Katelyn Souza, MSOT, OTR/L
	96 Peckham Rd, Acushnet, MA 02743-1713
	(774) 328-2052
	Not Available

Healthcare Provider's Profile

Full Name	Katelyn Souza
Gender	Female
Speciality	Occupational Therapist
Location	96 Peckham Rd, Acushnet, Massachusetts
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1144804923
Provider Enumeration Date: 05/08/2021
Last Update Date: 05/08/2021

Medical Identifiers

Medical identifiers for Katelyn Souza such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1144804923	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225X00000X	Occupational Therapist	13967 (Massachusetts)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Katelyn Souza is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Katelyn Souza, MSOT, OTR/L 96 Peckham Rd, Acushnet, MA 02743-1713 Ph: () -	Katelyn Souza, MSOT, OTR/L 96 Peckham Rd, Acushnet, MA 02743-1713 Ph: (774) 328-2052

News Archive

Unique biomarker in urine may offer non-invasive means of detecting prostate cancer

A research study published in the journal Neoplasia and led by principal investigator Nallasivam Palanisamy, Ph.D., associate scientist in the Vattikuti Urology Institute at Henry Ford Health System, has identified a novel prostate cancer gene fusion involving the KLK4 protein coding gene and KLKP1 pseudogene.

First generic cultivate(R) cream to receive tentative FDA approval

Atrix Laboratories, Inc. announced today the company received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for fluticasone propionate cream, 0.05%.

New Saint Louis University research finds SIDS strikes premies later

Because premature and small babies are at risk for SIDS later and longer than full-term infants, pediatricians should adjust when they offer counseling to parents about preventing SIDS, according to research published by a Saint Louis University pediatrician who examined more than 8,000 SIDS deaths.

Older and non-White people less likely to be captured by mobility data used in response to COVID-19

Information on individuals' mobility-where they go as measured by their smartphones-has been used widely in devising and evaluating ways to respond to COVID-19, including how to target public health resources.

Katelyn Souza, MSOT, OTR/L - Occupational Therapist in Acushnet, MA